Proceedings of the II National Academic Congress of Dermatology

    January 2022
    Image of study
    TLDR Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.
    The document from the II Congresso Nacional Acadêmico de Dermatologia reviewed various dermatological topics, including the increased incidence of telogen effluvium (TE) during the COVID-19 pandemic, particularly in severe cases. It discussed the promising use of Ruxolitinib 1.5% cream for vitiligo, highlighting its potential for repigmentation with minimal side effects. The efficacy of Mohs micrographic surgery for skin cancer was emphasized, along with the role of high-frequency ultrasound in cosmetic procedures. The document also noted the potential of immunotherapy for metastatic Merkel cell carcinoma and the benefits of probiotics and prebiotics for atopic dermatitis. Additionally, it addressed skin conditions in health workers during the pandemic and the importance of early melanoma diagnosis and sun protection.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results

    Related Community Posts Join

    6 / 631 results

    Similar Research

    5 / 1000+ results
      Alopecia in General Medicine

      research Alopecia in General Medicine

      13 citations , February 2016 in “Clinical Medicine”
      The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.
      Diagnosis and Management of Hair Loss in Children

      research Diagnosis and Management of Hair Loss in Children

      1 citations , May 2016 in “Current Opinion in Pediatrics”
      Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.